Development of a Paediatric Physiologically Based Pharmacokinetic Model to Assess the Impact of Drug-Drug Interactions in Tuberculosis Co-Infected Malaria Subjects: A Case Study With Artemether-Lumefantrine and the CYP3A4-inducer Rifampicin

European Journal of Pharmaceutical Sciences - Netherlands

doi 10.1016/j.ejps.2017.05.043